Israel Englander Aadi Bioscience, Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 226,085 shares of AADI stock, worth $479,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares

226,085

Holding current value

$479,300

% of portfolio

0.0%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.46 - $2.31 $330,084 - $522,256	226,085 New	226,085 $330,000
Q1 2023 May 15, 2023	SELL	$6.85 - $13.0 $15,165 - $28,782	-2,214 Reduced 2.97%	72,375 $524,000
Q4 2022 Feb 14, 2023	SELL	$11.99 - $14.5 $995,493 - $1.2 Million	-83,027 Reduced 52.68%	74,589 $957,000
Q3 2022 Nov 14, 2022	BUY	$12.03 - $14.22 $1.54 Million - $1.82 Million	127,652 Added 426.02%	157,616 $2.23 Million

Others Institutions Holding AADI

# of Institutions

Shares Held

14M

Call Options Held

9.4K

Put Options Held

2.5K

View Full List

About Aadi Bioscience, Inc.

Ticker AADI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,016,800
Market Cap $44.6M
Description
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...

More about AADI

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account